These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 29138848)
1. Fli‑1 promotes metastasis by regulating MMP2 signaling in hepatocellular carcinoma. Wang H; Ou Y; Ou J; Jian Z Mol Med Rep; 2018 Jan; 17(1):1986-1992. PubMed ID: 29138848 [TBL] [Abstract][Full Text] [Related]
2. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1. Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288 [TBL] [Abstract][Full Text] [Related]
3. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012 [TBL] [Abstract][Full Text] [Related]
4. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation. Huang D; Du X; Yuan R; Chen L; Liu T; Wen C; Huang M; Li M; Hao L; Shao J Biochem Biophys Res Commun; 2014 Oct; 453(1):49-56. PubMed ID: 25251472 [TBL] [Abstract][Full Text] [Related]
5. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004 [TBL] [Abstract][Full Text] [Related]
6. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor. Lou L; Chen YX; Jin L; Li X; Tao X; Zhu J; Chen X; Wu S; Ye W; He J; Ding G J Int Med Res; 2013 Feb; 41(1):55-63. PubMed ID: 23569130 [TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
9. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171 [TBL] [Abstract][Full Text] [Related]
10. Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2. Chen Y; Yu Y; Sun S; Wang Z; Liu P; Liu S; Jiang J Exp Cell Res; 2016 Nov; 349(1):68-76. PubMed ID: 27693494 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Du R; Wu S; Lv X; Fang H; Wu S; Kang J J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255 [TBL] [Abstract][Full Text] [Related]
12. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity. Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945 [TBL] [Abstract][Full Text] [Related]
13. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318 [TBL] [Abstract][Full Text] [Related]
15. Slit2 and Robo1 induce opposing effects on metastasis of hepatocellular carcinoma Sk-hep-1 cells. Yuan M; Guo H; Li J; Sui C; Qin Y; Wang J; Khan YH; Ye L; Xie F; Wang H; Yuan L; Ye J Int J Oncol; 2016 Jul; 49(1):305-15. PubMed ID: 27176045 [TBL] [Abstract][Full Text] [Related]
16. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma. Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092 [TBL] [Abstract][Full Text] [Related]